Singapore markets open in 3 hours 21 minutes

Abbott Laboratories (ABT)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
109.45+3.24 (+3.05%)
At close: 04:06PM EDT
109.00 -0.45 (-0.41%)
After hours: 07:56PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
44,514,000
43,075,000
34,608,000
31,904,000
30,578,000
Cost of revenue
19,123,000
18,537,000
15,003,000
13,231,000
12,706,000
Gross profit
25,391,000
24,538,000
19,605,000
18,673,000
17,872,000
Operating expenses
Research development
2,785,000
2,742,000
2,420,000
2,440,000
2,300,000
Selling general and administrative
11,328,000
11,324,000
9,696,000
9,765,000
9,744,000
Total operating expenses
16,163,000
16,113,000
14,248,000
14,141,000
14,222,000
Operating income or loss
9,228,000
8,425,000
5,357,000
4,532,000
3,650,000
Interest expense
529,000
533,000
546,000
670,000
826,000
Total other income/expenses net
299,000
276,000
111,000
121,000
-56,000
Income before tax
9,044,000
8,211,000
4,968,000
4,077,000
2,873,000
Income tax expense
1,319,000
1,140,000
497,000
390,000
539,000
Income from continuing operations
7,725,000
7,071,000
4,471,000
3,687,000
2,334,000
Net income
7,725,000
7,071,000
4,495,000
3,687,000
2,368,000
Net income available to common shareholders
7,725,000
7,071,000
4,495,000
3,687,000
2,368,000
Basic EPS
-
4.01
2.54
2.09
1.35
Diluted EPS
-
3.94
2.50
2.06
1.33
Basic average shares
-
1,764,082
1,771,230
1,762,503
1,755,619
Diluted average shares
-
1,789,000
1,786,000
1,781,000
1,770,000
EBITDA
-
12,282,000
8,841,000
7,761,000
6,977,000